NeuroBo Pharmaceuticals Shares Outstanding 1970-1969 | MTVA
NeuroBo Pharmaceuticals shares outstanding from 1970 to 1969. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
NeuroBo Pharmaceuticals Annual Shares Outstanding
(Millions of Shares) |
NeuroBo Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares) |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.022B |
$0.000B |
|
NeuroBo Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on novel treatments for neurodegenerative diseases. The company's novel lead candidate NB-01 is a drug candidate for diabetic neuropathic pain. NB-02 focuses on the treatment of neurodegenerative diseases. NeuroBo Pharmaceuticals Inc., formerly known as Gemphire Therapeutics Inc., is based in Northville, United States.
|
